PTPRC and acute myeloid leukemia: Further, in the AML xenografted nude mice model, PRT4165 encapsulated HSANPs showed enhanced in vivo biodistribution, enhanced dispersibility, and biocompatibility, in turn positively influencing the suppression of leukemia stem cell marker, CD45+, and activation of myeloid monocytes differentiation marker, CD11b+.193